nodes	percent_of_prediction	percent_of_DWPC	metapath
Chenodeoxycholic acid—Drostanolone—Progesterone—uterine cancer	0.491	1	CrCrCtD
Chenodeoxycholic acid—UGT2B7—Epirubicin—uterine cancer	0.14	0.632	CbGbCtD
Chenodeoxycholic acid—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.0377	0.17	CbGbCtD
Chenodeoxycholic acid—CYP3A4—Progesterone—uterine cancer	0.025	0.113	CbGbCtD
Chenodeoxycholic acid—CYP3A4—Etoposide—uterine cancer	0.0112	0.0505	CbGbCtD
Chenodeoxycholic acid—CYP3A4—Doxorubicin—uterine cancer	0.00763	0.0345	CbGbCtD
Chenodeoxycholic acid—CYP27A1—Synthesis of bile acids and bile salts via 24-hydroxycholesterol—AKR1C1—uterine cancer	0.00518	0.0549	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Synthesis of bile acids and bile salts via 27-hydroxycholesterol—AKR1C1—uterine cancer	0.0049	0.0519	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Synthesis of bile acids and bile salts via 24-hydroxycholesterol—AKR1C3—uterine cancer	0.00399	0.0422	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Synthesis of bile acids and bile salts via 27-hydroxycholesterol—AKR1C3—uterine cancer	0.00377	0.04	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Synthesis of bile acids and bile salts via 27-hydroxycholesterol—AKR1C1—uterine cancer	0.00358	0.0379	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol—AKR1C1—uterine cancer	0.00337	0.0357	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Synthesis of bile acids and bile salts—AKR1C1—uterine cancer	0.00306	0.0324	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—renal system—uterine cancer	0.00306	0.0902	CbGeAlD
Chenodeoxycholic acid—CYP27A1—myometrium—uterine cancer	0.00306	0.0902	CbGeAlD
Chenodeoxycholic acid—CYP27A1—Endogenous sterols—CYP11A1—uterine cancer	0.00284	0.0301	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Synthesis of bile acids and bile salts via 27-hydroxycholesterol—AKR1C3—uterine cancer	0.00276	0.0292	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol—AKR1C3—uterine cancer	0.00259	0.0274	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol—AKR1C1—uterine cancer	0.00246	0.0261	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—female reproductive system—uterine cancer	0.00245	0.0722	CbGeAlD
Chenodeoxycholic acid—CYP27A1—Bile acid and bile salt metabolism—AKR1C1—uterine cancer	0.00243	0.0258	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—uterine cervix—uterine cancer	0.00238	0.0702	CbGeAlD
Chenodeoxycholic acid—CYP27A1—Synthesis of bile acids and bile salts—AKR1C3—uterine cancer	0.00236	0.025	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—decidua—uterine cancer	0.00227	0.0669	CbGeAlD
Chenodeoxycholic acid—NR1H4—Synthesis of bile acids and bile salts—AKR1C1—uterine cancer	0.00224	0.0237	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—female gonad—uterine cancer	0.00223	0.0657	CbGeAlD
Chenodeoxycholic acid—CYP27A1—renal system—uterine cancer	0.00223	0.0656	CbGeAlD
Chenodeoxycholic acid—CYP27A1—endometrium—uterine cancer	0.00215	0.0635	CbGeAlD
Chenodeoxycholic acid—CYP27A1—Endogenous sterols—CYP19A1—uterine cancer	0.00209	0.0221	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—mammalian vulva—uterine cancer	0.00208	0.0614	CbGeAlD
Chenodeoxycholic acid—NR1H4—Endogenous sterols—CYP11A1—uterine cancer	0.00207	0.022	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—renal system—uterine cancer	0.00197	0.0581	CbGeAlD
Chenodeoxycholic acid—NR1H4—Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol—AKR1C3—uterine cancer	0.00189	0.0201	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Bile acid and bile salt metabolism—AKR1C3—uterine cancer	0.00187	0.0198	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—female reproductive system—uterine cancer	0.00178	0.0526	CbGeAlD
Chenodeoxycholic acid—NR1H4—Bile acid and bile salt metabolism—AKR1C1—uterine cancer	0.00178	0.0188	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Synthesis of bile acids and bile salts—AKR1C3—uterine cancer	0.00172	0.0183	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—female gonad—uterine cancer	0.00162	0.0478	CbGeAlD
Chenodeoxycholic acid—Drostanolone—CYP19A1—uterine cancer	0.00162	1	CrCbGaD
Chenodeoxycholic acid—CYP27A1—vagina—uterine cancer	0.00161	0.0476	CbGeAlD
Chenodeoxycholic acid—UGT2B7—female reproductive system—uterine cancer	0.00158	0.0465	CbGeAlD
Chenodeoxycholic acid—NR1H4—Endogenous sterols—CYP19A1—uterine cancer	0.00153	0.0162	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—lymph node—uterine cancer	0.00143	0.0423	CbGeAlD
Chenodeoxycholic acid—NR1H4—Bile acid and bile salt metabolism—AKR1C3—uterine cancer	0.00137	0.0145	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Cytochrome P450 - arranged by substrate type—CYP11A1—uterine cancer	0.00132	0.014	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Oxidation by Cytochrome P450—CYP11A1—uterine cancer	0.0013	0.0138	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Phase 1 - Functionalization of compounds—CYP11A1—uterine cancer	0.00107	0.0113	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—lymph node—uterine cancer	0.00104	0.0308	CbGeAlD
Chenodeoxycholic acid—NR1H4—Nuclear Receptor transcription pathway—PGR—uterine cancer	0.00101	0.0107	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metapathway biotransformation—AKR1B10—uterine cancer	0.00101	0.0107	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Cytochrome P450 - arranged by substrate type—CYP19A1—uterine cancer	0.00097	0.0103	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Cytochrome P450 - arranged by substrate type—CYP11A1—uterine cancer	0.000963	0.0102	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Oxidation by Cytochrome P450—CYP19A1—uterine cancer	0.000957	0.0101	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metapathway biotransformation—AKR1B1—uterine cancer	0.000936	0.00991	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Nuclear Receptor transcription pathway—ESR2—uterine cancer	0.000889	0.00942	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	0.000786	0.00833	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Phase 1 - Functionalization of compounds—CYP11A1—uterine cancer	0.000781	0.00827	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Benzo(a)pyrene metabolism—AKR1C1—uterine cancer	0.000771	0.00817	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Cytochrome P450 - arranged by substrate type—CYP19A1—uterine cancer	0.000709	0.00751	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metapathway biotransformation—AKR1C1—uterine cancer	0.000687	0.00728	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metapathway biotransformation—GPX3—uterine cancer	0.000603	0.00639	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Benzo(a)pyrene metabolism—AKR1C3—uterine cancer	0.000594	0.00629	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	0.000574	0.00609	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Biological oxidations—CYP11A1—uterine cancer	0.000568	0.00601	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metapathway biotransformation—CYP11A1—uterine cancer	0.00056	0.00593	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Nuclear Receptor transcription pathway—ESR1—uterine cancer	0.000539	0.00571	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—renal system—uterine cancer	0.000537	0.0158	CbGeAlD
Chenodeoxycholic acid—CYP27A1—Metapathway biotransformation—AKR1C3—uterine cancer	0.000529	0.0056	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	0.000504	0.00534	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metapathway biotransformation—AKR1B10—uterine cancer	0.000458	0.00486	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—female reproductive system—uterine cancer	0.00043	0.0127	CbGeAlD
Chenodeoxycholic acid—UGT2B7—Metapathway biotransformation—AKR1B1—uterine cancer	0.000426	0.00451	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Biological oxidations—CYP19A1—uterine cancer	0.000418	0.00442	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Biological oxidations—CYP11A1—uterine cancer	0.000415	0.00439	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metapathway biotransformation—CYP19A1—uterine cancer	0.000412	0.00436	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	0.000368	0.0039	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	0.000364	0.00386	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism of lipids and lipoproteins—STAR—uterine cancer	0.000364	0.00386	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—NRF2 pathway—NFE2L2—uterine cancer	0.000333	0.00353	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—NRF2 pathway—GPX3—uterine cancer	0.000317	0.00336	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metapathway biotransformation—AKR1C1—uterine cancer	0.000313	0.00331	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Biological oxidations—CYP19A1—uterine cancer	0.000305	0.00323	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metapathway biotransformation—GPX3—uterine cancer	0.000275	0.00291	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	0.000267	0.00283	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism of lipids and lipoproteins—STAR—uterine cancer	0.000266	0.00282	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	0.000266	0.00282	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Biological oxidations—CYP11A1—uterine cancer	0.000259	0.00274	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metapathway biotransformation—CYP11A1—uterine cancer	0.000255	0.0027	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Transmembrane transport of small molecules—ABCC9—uterine cancer	0.000253	0.00268	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metapathway biotransformation—AKR1C3—uterine cancer	0.000241	0.00255	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Gene Expression—PHF1—uterine cancer	0.000237	0.00251	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—NDUFB11—uterine cancer	0.000224	0.00238	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—SRD5A2—uterine cancer	0.000224	0.00238	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	0.000218	0.00231	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	0.000206	0.00218	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Gene Expression—CHD4—uterine cancer	0.000201	0.00213	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	0.000195	0.00207	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Biological oxidations—CYP19A1—uterine cancer	0.00019	0.00201	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metapathway biotransformation—CYP19A1—uterine cancer	0.000188	0.00199	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Generic Transcription Pathway—PGR—uterine cancer	0.000174	0.00185	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—PPARA activates gene expression—EP300—uterine cancer	0.000174	0.00184	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—uterine cancer	0.00017	0.0018	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Gene Expression—SUZ12—uterine cancer	0.000169	0.00179	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—NDUFB11—uterine cancer	0.000164	0.00174	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—SRD5A2—uterine cancer	0.000164	0.00174	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—STAR—uterine cancer	0.000162	0.00172	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—AKR1B1—uterine cancer	0.000162	0.00172	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	0.00016	0.0017	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	0.000159	0.00169	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Generic Transcription Pathway—ESR2—uterine cancer	0.000154	0.00163	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	0.00015	0.00159	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP11A1—uterine cancer	0.000138	0.00146	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Oxidation by Cytochrome P450—CYP11A1—uterine cancer	0.000136	0.00144	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—POLD1—uterine cancer	0.000127	0.00135	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Tryptophan metabolism—CYP19A1—uterine cancer	0.000125	0.00133	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Generic Transcription Pathway—CDKN2B—uterine cancer	0.000125	0.00132	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—AKR1C1—uterine cancer	0.000119	0.00126	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—AKR1B1—uterine cancer	0.000119	0.00126	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—STAR—uterine cancer	0.000119	0.00126	CbGpPWpGaD
Chenodeoxycholic acid—Confusional state—Etoposide—uterine cancer	0.000117	0.000742	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—uterine cancer	0.000117	0.00124	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	0.000117	0.00124	CbGpPWpGaD
Chenodeoxycholic acid—Alanine aminotransferase increased—Epirubicin—uterine cancer	0.000117	0.00074	CcSEcCtD
Chenodeoxycholic acid—Infection—Etoposide—uterine cancer	0.000116	0.000731	CcSEcCtD
Chenodeoxycholic acid—Asthenia—Dactinomycin—uterine cancer	0.000115	0.000729	CcSEcCtD
Chenodeoxycholic acid—Blood creatinine increased—Doxorubicin—uterine cancer	0.000115	0.000727	CcSEcCtD
Chenodeoxycholic acid—Asthma—Epirubicin—uterine cancer	0.000115	0.000725	CcSEcCtD
Chenodeoxycholic acid—Dysphagia—Epirubicin—uterine cancer	0.000115	0.000725	CcSEcCtD
Chenodeoxycholic acid—Influenza—Epirubicin—uterine cancer	0.000115	0.000725	CcSEcCtD
Chenodeoxycholic acid—Dehydration—Doxorubicin—uterine cancer	0.000114	0.000722	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Generic Transcription Pathway—SMAD3—uterine cancer	0.000114	0.00121	CbGpPWpGaD
Chenodeoxycholic acid—Thrombocytopenia—Etoposide—uterine cancer	0.000114	0.00072	CcSEcCtD
Chenodeoxycholic acid—Tachycardia—Etoposide—uterine cancer	0.000114	0.000718	CcSEcCtD
Chenodeoxycholic acid—Liver function test abnormal—Doxorubicin—uterine cancer	0.000113	0.000717	CcSEcCtD
Chenodeoxycholic acid—Skin disorder—Etoposide—uterine cancer	0.000113	0.000714	CcSEcCtD
Chenodeoxycholic acid—Hyperhidrosis—Etoposide—uterine cancer	0.000113	0.000711	CcSEcCtD
Chenodeoxycholic acid—Pancreatitis—Epirubicin—uterine cancer	0.000112	0.000711	CcSEcCtD
Chenodeoxycholic acid—Orthostatic hypotension—Doxorubicin—uterine cancer	0.000112	0.000709	CcSEcCtD
Chenodeoxycholic acid—Abdominal pain upper—Doxorubicin—uterine cancer	0.000112	0.000709	CcSEcCtD
Chenodeoxycholic acid—Angina pectoris—Epirubicin—uterine cancer	0.000112	0.000706	CcSEcCtD
Chenodeoxycholic acid—CYP3A4—Phase 1 - Functionalization of compounds—CYP11A1—uterine cancer	0.000112	0.00118	CbGpPWpGaD
Chenodeoxycholic acid—Breast disorder—Doxorubicin—uterine cancer	0.000111	0.000701	CcSEcCtD
Chenodeoxycholic acid—Anorexia—Etoposide—uterine cancer	0.000111	0.000701	CcSEcCtD
Chenodeoxycholic acid—Aspartate aminotransferase increased—Doxorubicin—uterine cancer	0.000111	0.000699	CcSEcCtD
Chenodeoxycholic acid—Bronchitis—Epirubicin—uterine cancer	0.00011	0.000697	CcSEcCtD
Chenodeoxycholic acid—Diarrhoea—Dactinomycin—uterine cancer	0.00011	0.000695	CcSEcCtD
Chenodeoxycholic acid—Hypotension—Etoposide—uterine cancer	0.000109	0.000687	CcSEcCtD
Chenodeoxycholic acid—Gastritis—Doxorubicin—uterine cancer	0.000109	0.000687	CcSEcCtD
Chenodeoxycholic acid—Alanine aminotransferase increased—Doxorubicin—uterine cancer	0.000108	0.000685	CcSEcCtD
Chenodeoxycholic acid—Dysuria—Epirubicin—uterine cancer	0.000107	0.000678	CcSEcCtD
Chenodeoxycholic acid—Upper respiratory tract infection—Epirubicin—uterine cancer	0.000107	0.000674	CcSEcCtD
Chenodeoxycholic acid—Dysphagia—Doxorubicin—uterine cancer	0.000106	0.000671	CcSEcCtD
Chenodeoxycholic acid—Asthma—Doxorubicin—uterine cancer	0.000106	0.000671	CcSEcCtD
Chenodeoxycholic acid—Influenza—Doxorubicin—uterine cancer	0.000106	0.000671	CcSEcCtD
Chenodeoxycholic acid—CYP27A1—Metabolism—RRM2—uterine cancer	0.000106	0.00112	CbGpPWpGaD
Chenodeoxycholic acid—Pollakiuria—Epirubicin—uterine cancer	0.000106	0.00067	CcSEcCtD
Chenodeoxycholic acid—CYP3A4—Metapathway biotransformation—AKR1B10—uterine cancer	0.000105	0.00112	CbGpPWpGaD
Chenodeoxycholic acid—Photosensitivity reaction—Epirubicin—uterine cancer	0.000105	0.000662	CcSEcCtD
Chenodeoxycholic acid—Paraesthesia—Etoposide—uterine cancer	0.000105	0.00066	CcSEcCtD
Chenodeoxycholic acid—Weight increased—Epirubicin—uterine cancer	0.000104	0.00066	CcSEcCtD
Chenodeoxycholic acid—Pancreatitis—Doxorubicin—uterine cancer	0.000104	0.000658	CcSEcCtD
Chenodeoxycholic acid—Weight decreased—Epirubicin—uterine cancer	0.000104	0.000656	CcSEcCtD
Chenodeoxycholic acid—Dyspnoea—Etoposide—uterine cancer	0.000104	0.000656	CcSEcCtD
Chenodeoxycholic acid—Somnolence—Etoposide—uterine cancer	0.000103	0.000654	CcSEcCtD
Chenodeoxycholic acid—Angina pectoris—Doxorubicin—uterine cancer	0.000103	0.000653	CcSEcCtD
Chenodeoxycholic acid—CYP27A1—Metabolism—DCN—uterine cancer	0.000103	0.00109	CbGpPWpGaD
Chenodeoxycholic acid—Pneumonia—Epirubicin—uterine cancer	0.000103	0.00065	CcSEcCtD
Chenodeoxycholic acid—Infestation NOS—Epirubicin—uterine cancer	0.000102	0.000646	CcSEcCtD
Chenodeoxycholic acid—Infestation—Epirubicin—uterine cancer	0.000102	0.000646	CcSEcCtD
Chenodeoxycholic acid—Vomiting—Dactinomycin—uterine cancer	0.000102	0.000646	CcSEcCtD
Chenodeoxycholic acid—UGT2B7—Metabolism—SRD5A2—uterine cancer	0.000102	0.00108	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—NDUFB11—uterine cancer	0.000102	0.00108	CbGpPWpGaD
Chenodeoxycholic acid—Bronchitis—Doxorubicin—uterine cancer	0.000102	0.000645	CcSEcCtD
Chenodeoxycholic acid—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—uterine cancer	0.000101	0.00107	CbGpPWpGaD
Chenodeoxycholic acid—Rash—Dactinomycin—uterine cancer	0.000101	0.000641	CcSEcCtD
Chenodeoxycholic acid—Decreased appetite—Etoposide—uterine cancer	0.000101	0.000639	CcSEcCtD
Chenodeoxycholic acid—Renal failure—Epirubicin—uterine cancer	0.000101	0.000635	CcSEcCtD
Chenodeoxycholic acid—Gastrointestinal disorder—Etoposide—uterine cancer	0.0001	0.000635	CcSEcCtD
Chenodeoxycholic acid—Fatigue—Etoposide—uterine cancer	0.0001	0.000634	CcSEcCtD
Chenodeoxycholic acid—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—uterine cancer	0.0001	0.00106	CbGpPWpGaD
Chenodeoxycholic acid—Jaundice—Epirubicin—uterine cancer	9.97e-05	0.00063	CcSEcCtD
Chenodeoxycholic acid—Constipation—Etoposide—uterine cancer	9.95e-05	0.000629	CcSEcCtD
Chenodeoxycholic acid—Pain—Etoposide—uterine cancer	9.95e-05	0.000629	CcSEcCtD
Chenodeoxycholic acid—Conjunctivitis—Epirubicin—uterine cancer	9.94e-05	0.000628	CcSEcCtD
Chenodeoxycholic acid—Urinary tract infection—Epirubicin—uterine cancer	9.94e-05	0.000628	CcSEcCtD
Chenodeoxycholic acid—Dysuria—Doxorubicin—uterine cancer	9.93e-05	0.000627	CcSEcCtD
Chenodeoxycholic acid—Upper respiratory tract infection—Doxorubicin—uterine cancer	9.87e-05	0.000623	CcSEcCtD
Chenodeoxycholic acid—Sweating—Epirubicin—uterine cancer	9.81e-05	0.00062	CcSEcCtD
Chenodeoxycholic acid—Pollakiuria—Doxorubicin—uterine cancer	9.81e-05	0.00062	CcSEcCtD
Chenodeoxycholic acid—CYP3A4—Metapathway biotransformation—AKR1B1—uterine cancer	9.79e-05	0.00104	CbGpPWpGaD
Chenodeoxycholic acid—Haematuria—Epirubicin—uterine cancer	9.75e-05	0.000616	CcSEcCtD
Chenodeoxycholic acid—CYP27A1—Metabolism—CYP11A1—uterine cancer	9.71e-05	0.00103	CbGpPWpGaD
Chenodeoxycholic acid—Photosensitivity reaction—Doxorubicin—uterine cancer	9.69e-05	0.000612	CcSEcCtD
Chenodeoxycholic acid—Hepatobiliary disease—Epirubicin—uterine cancer	9.68e-05	0.000611	CcSEcCtD
Chenodeoxycholic acid—Weight increased—Doxorubicin—uterine cancer	9.66e-05	0.00061	CcSEcCtD
Chenodeoxycholic acid—Epistaxis—Epirubicin—uterine cancer	9.65e-05	0.00061	CcSEcCtD
Chenodeoxycholic acid—Weight decreased—Doxorubicin—uterine cancer	9.61e-05	0.000607	CcSEcCtD
Chenodeoxycholic acid—Sinusitis—Epirubicin—uterine cancer	9.6e-05	0.000606	CcSEcCtD
Chenodeoxycholic acid—Feeling abnormal—Etoposide—uterine cancer	9.59e-05	0.000606	CcSEcCtD
Chenodeoxycholic acid—Nausea—Dactinomycin—uterine cancer	9.55e-05	0.000604	CcSEcCtD
Chenodeoxycholic acid—Pneumonia—Doxorubicin—uterine cancer	9.52e-05	0.000602	CcSEcCtD
Chenodeoxycholic acid—Gastrointestinal pain—Etoposide—uterine cancer	9.52e-05	0.000601	CcSEcCtD
Chenodeoxycholic acid—Infestation—Doxorubicin—uterine cancer	9.47e-05	0.000598	CcSEcCtD
Chenodeoxycholic acid—Infestation NOS—Doxorubicin—uterine cancer	9.47e-05	0.000598	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Generic Transcription Pathway—ESR1—uterine cancer	9.31e-05	0.000986	CbGpPWpGaD
Chenodeoxycholic acid—Renal failure—Doxorubicin—uterine cancer	9.31e-05	0.000588	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Metabolism—POLD1—uterine cancer	9.3e-05	0.000986	CbGpPWpGaD
Chenodeoxycholic acid—Urticaria—Etoposide—uterine cancer	9.25e-05	0.000584	CcSEcCtD
Chenodeoxycholic acid—Haemoglobin—Epirubicin—uterine cancer	9.23e-05	0.000583	CcSEcCtD
Chenodeoxycholic acid—Jaundice—Doxorubicin—uterine cancer	9.23e-05	0.000583	CcSEcCtD
Chenodeoxycholic acid—Rhinitis—Epirubicin—uterine cancer	9.21e-05	0.000582	CcSEcCtD
Chenodeoxycholic acid—Abdominal pain—Etoposide—uterine cancer	9.2e-05	0.000581	CcSEcCtD
Chenodeoxycholic acid—Body temperature increased—Etoposide—uterine cancer	9.2e-05	0.000581	CcSEcCtD
Chenodeoxycholic acid—Conjunctivitis—Doxorubicin—uterine cancer	9.2e-05	0.000581	CcSEcCtD
Chenodeoxycholic acid—Urinary tract infection—Doxorubicin—uterine cancer	9.2e-05	0.000581	CcSEcCtD
Chenodeoxycholic acid—Haemorrhage—Epirubicin—uterine cancer	9.18e-05	0.00058	CcSEcCtD
Chenodeoxycholic acid—CYP27A1—Metabolism—AKR1C3—uterine cancer	9.17e-05	0.000971	CbGpPWpGaD
Chenodeoxycholic acid—Pharyngitis—Epirubicin—uterine cancer	9.12e-05	0.000576	CcSEcCtD
Chenodeoxycholic acid—Sweating—Doxorubicin—uterine cancer	9.08e-05	0.000573	CcSEcCtD
Chenodeoxycholic acid—Urinary tract disorder—Epirubicin—uterine cancer	9.07e-05	0.000573	CcSEcCtD
Chenodeoxycholic acid—Oedema peripheral—Epirubicin—uterine cancer	9.05e-05	0.000572	CcSEcCtD
Chenodeoxycholic acid—Haematuria—Doxorubicin—uterine cancer	9.03e-05	0.00057	CcSEcCtD
Chenodeoxycholic acid—Connective tissue disorder—Epirubicin—uterine cancer	9.03e-05	0.00057	CcSEcCtD
Chenodeoxycholic acid—Urethral disorder—Epirubicin—uterine cancer	9e-05	0.000569	CcSEcCtD
Chenodeoxycholic acid—Hepatobiliary disease—Doxorubicin—uterine cancer	8.95e-05	0.000566	CcSEcCtD
Chenodeoxycholic acid—Epistaxis—Doxorubicin—uterine cancer	8.93e-05	0.000564	CcSEcCtD
Chenodeoxycholic acid—Sinusitis—Doxorubicin—uterine cancer	8.88e-05	0.000561	CcSEcCtD
Chenodeoxycholic acid—Visual impairment—Epirubicin—uterine cancer	8.85e-05	0.000559	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Metabolism—AKR1C1—uterine cancer	8.7e-05	0.000922	CbGpPWpGaD
Chenodeoxycholic acid—Eye disorder—Epirubicin—uterine cancer	8.58e-05	0.000542	CcSEcCtD
Chenodeoxycholic acid—Hypersensitivity—Etoposide—uterine cancer	8.58e-05	0.000542	CcSEcCtD
Chenodeoxycholic acid—Tinnitus—Epirubicin—uterine cancer	8.56e-05	0.000541	CcSEcCtD
Chenodeoxycholic acid—Haemoglobin—Doxorubicin—uterine cancer	8.54e-05	0.00054	CcSEcCtD
Chenodeoxycholic acid—Cardiac disorder—Epirubicin—uterine cancer	8.52e-05	0.000539	CcSEcCtD
Chenodeoxycholic acid—Rhinitis—Doxorubicin—uterine cancer	8.52e-05	0.000538	CcSEcCtD
Chenodeoxycholic acid—Haemorrhage—Doxorubicin—uterine cancer	8.5e-05	0.000537	CcSEcCtD
Chenodeoxycholic acid—Pharyngitis—Doxorubicin—uterine cancer	8.43e-05	0.000533	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Gene Expression—PGR—uterine cancer	8.39e-05	0.000889	CbGpPWpGaD
Chenodeoxycholic acid—Urinary tract disorder—Doxorubicin—uterine cancer	8.39e-05	0.00053	CcSEcCtD
Chenodeoxycholic acid—Oedema peripheral—Doxorubicin—uterine cancer	8.37e-05	0.000529	CcSEcCtD
Chenodeoxycholic acid—Asthenia—Etoposide—uterine cancer	8.35e-05	0.000528	CcSEcCtD
Chenodeoxycholic acid—Connective tissue disorder—Doxorubicin—uterine cancer	8.35e-05	0.000528	CcSEcCtD
Chenodeoxycholic acid—Angiopathy—Epirubicin—uterine cancer	8.33e-05	0.000526	CcSEcCtD
Chenodeoxycholic acid—Urethral disorder—Doxorubicin—uterine cancer	8.33e-05	0.000526	CcSEcCtD
Chenodeoxycholic acid—Immune system disorder—Epirubicin—uterine cancer	8.3e-05	0.000524	CcSEcCtD
Chenodeoxycholic acid—Mediastinal disorder—Epirubicin—uterine cancer	8.28e-05	0.000523	CcSEcCtD
Chenodeoxycholic acid—Chills—Epirubicin—uterine cancer	8.24e-05	0.000521	CcSEcCtD
Chenodeoxycholic acid—Pruritus—Etoposide—uterine cancer	8.24e-05	0.00052	CcSEcCtD
Chenodeoxycholic acid—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	8.22e-05	0.000871	CbGpPWpGaD
Chenodeoxycholic acid—Arrhythmia—Epirubicin—uterine cancer	8.2e-05	0.000518	CcSEcCtD
Chenodeoxycholic acid—Visual impairment—Doxorubicin—uterine cancer	8.19e-05	0.000517	CcSEcCtD
Chenodeoxycholic acid—Alopecia—Epirubicin—uterine cancer	8.12e-05	0.000513	CcSEcCtD
Chenodeoxycholic acid—Malnutrition—Epirubicin—uterine cancer	8e-05	0.000505	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Gene Expression—EZH2—uterine cancer	7.97e-05	0.000845	CbGpPWpGaD
Chenodeoxycholic acid—Diarrhoea—Etoposide—uterine cancer	7.96e-05	0.000503	CcSEcCtD
Chenodeoxycholic acid—Eye disorder—Doxorubicin—uterine cancer	7.94e-05	0.000502	CcSEcCtD
Chenodeoxycholic acid—Tinnitus—Doxorubicin—uterine cancer	7.92e-05	0.000501	CcSEcCtD
Chenodeoxycholic acid—Cardiac disorder—Doxorubicin—uterine cancer	7.89e-05	0.000498	CcSEcCtD
Chenodeoxycholic acid—Flatulence—Epirubicin—uterine cancer	7.88e-05	0.000498	CcSEcCtD
Chenodeoxycholic acid—Tension—Epirubicin—uterine cancer	7.85e-05	0.000496	CcSEcCtD
Chenodeoxycholic acid—Nervousness—Epirubicin—uterine cancer	7.77e-05	0.000491	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Metabolism—RRM2—uterine cancer	7.76e-05	0.000822	CbGpPWpGaD
Chenodeoxycholic acid—Back pain—Epirubicin—uterine cancer	7.73e-05	0.000489	CcSEcCtD
Chenodeoxycholic acid—Angiopathy—Doxorubicin—uterine cancer	7.71e-05	0.000487	CcSEcCtD
Chenodeoxycholic acid—Dizziness—Etoposide—uterine cancer	7.7e-05	0.000486	CcSEcCtD
Chenodeoxycholic acid—Muscle spasms—Epirubicin—uterine cancer	7.69e-05	0.000486	CcSEcCtD
Chenodeoxycholic acid—Immune system disorder—Doxorubicin—uterine cancer	7.68e-05	0.000485	CcSEcCtD
Chenodeoxycholic acid—Mediastinal disorder—Doxorubicin—uterine cancer	7.66e-05	0.000484	CcSEcCtD
Chenodeoxycholic acid—Chills—Doxorubicin—uterine cancer	7.63e-05	0.000482	CcSEcCtD
Chenodeoxycholic acid—Arrhythmia—Doxorubicin—uterine cancer	7.59e-05	0.00048	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Metabolism—DCN—uterine cancer	7.53e-05	0.000798	CbGpPWpGaD
Chenodeoxycholic acid—Alopecia—Doxorubicin—uterine cancer	7.51e-05	0.000474	CcSEcCtD
Chenodeoxycholic acid—Ill-defined disorder—Epirubicin—uterine cancer	7.42e-05	0.000469	CcSEcCtD
Chenodeoxycholic acid—Vomiting—Etoposide—uterine cancer	7.4e-05	0.000468	CcSEcCtD
Chenodeoxycholic acid—Malnutrition—Doxorubicin—uterine cancer	7.4e-05	0.000467	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Gene Expression—ESR2—uterine cancer	7.39e-05	0.000783	CbGpPWpGaD
Chenodeoxycholic acid—Anaemia—Epirubicin—uterine cancer	7.39e-05	0.000467	CcSEcCtD
Chenodeoxycholic acid—UGT2B7—Metabolism—STAR—uterine cancer	7.39e-05	0.000783	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—AKR1B1—uterine cancer	7.39e-05	0.000783	CbGpPWpGaD
Chenodeoxycholic acid—Rash—Etoposide—uterine cancer	7.34e-05	0.000464	CcSEcCtD
Chenodeoxycholic acid—Dermatitis—Etoposide—uterine cancer	7.33e-05	0.000463	CcSEcCtD
Chenodeoxycholic acid—Headache—Etoposide—uterine cancer	7.29e-05	0.000461	CcSEcCtD
Chenodeoxycholic acid—Flatulence—Doxorubicin—uterine cancer	7.29e-05	0.000461	CcSEcCtD
Chenodeoxycholic acid—Tension—Doxorubicin—uterine cancer	7.26e-05	0.000459	CcSEcCtD
Chenodeoxycholic acid—Malaise—Epirubicin—uterine cancer	7.21e-05	0.000456	CcSEcCtD
Chenodeoxycholic acid—Nervousness—Doxorubicin—uterine cancer	7.18e-05	0.000454	CcSEcCtD
Chenodeoxycholic acid—Vertigo—Epirubicin—uterine cancer	7.18e-05	0.000454	CcSEcCtD
Chenodeoxycholic acid—CYP3A4—Metapathway biotransformation—AKR1C1—uterine cancer	7.18e-05	0.000761	CbGpPWpGaD
Chenodeoxycholic acid—Syncope—Epirubicin—uterine cancer	7.17e-05	0.000453	CcSEcCtD
Chenodeoxycholic acid—Leukopenia—Epirubicin—uterine cancer	7.16e-05	0.000452	CcSEcCtD
Chenodeoxycholic acid—Back pain—Doxorubicin—uterine cancer	7.16e-05	0.000452	CcSEcCtD
Chenodeoxycholic acid—CYP27A1—Metabolism—STK11—uterine cancer	7.14e-05	0.000757	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—CYP19A1—uterine cancer	7.14e-05	0.000757	CbGpPWpGaD
Chenodeoxycholic acid—Muscle spasms—Doxorubicin—uterine cancer	7.11e-05	0.000449	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Metabolism—CYP11A1—uterine cancer	7.09e-05	0.000751	CbGpPWpGaD
Chenodeoxycholic acid—Palpitations—Epirubicin—uterine cancer	7.07e-05	0.000446	CcSEcCtD
Chenodeoxycholic acid—Loss of consciousness—Epirubicin—uterine cancer	7.03e-05	0.000444	CcSEcCtD
Chenodeoxycholic acid—Cough—Epirubicin—uterine cancer	6.98e-05	0.000441	CcSEcCtD
Chenodeoxycholic acid—Convulsion—Epirubicin—uterine cancer	6.93e-05	0.000438	CcSEcCtD
Chenodeoxycholic acid—Nausea—Etoposide—uterine cancer	6.91e-05	0.000437	CcSEcCtD
Chenodeoxycholic acid—Hypertension—Epirubicin—uterine cancer	6.9e-05	0.000436	CcSEcCtD
Chenodeoxycholic acid—Ill-defined disorder—Doxorubicin—uterine cancer	6.86e-05	0.000434	CcSEcCtD
Chenodeoxycholic acid—Anaemia—Doxorubicin—uterine cancer	6.84e-05	0.000432	CcSEcCtD
Chenodeoxycholic acid—Myalgia—Epirubicin—uterine cancer	6.81e-05	0.00043	CcSEcCtD
Chenodeoxycholic acid—Arthralgia—Epirubicin—uterine cancer	6.81e-05	0.00043	CcSEcCtD
Chenodeoxycholic acid—Chest pain—Epirubicin—uterine cancer	6.81e-05	0.00043	CcSEcCtD
Chenodeoxycholic acid—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	6.76e-05	0.000427	CcSEcCtD
Chenodeoxycholic acid—Discomfort—Epirubicin—uterine cancer	6.73e-05	0.000425	CcSEcCtD
Chenodeoxycholic acid—CYP27A1—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	6.7e-05	0.00071	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—AKR1C3—uterine cancer	6.7e-05	0.00071	CbGpPWpGaD
Chenodeoxycholic acid—Malaise—Doxorubicin—uterine cancer	6.67e-05	0.000422	CcSEcCtD
Chenodeoxycholic acid—Dry mouth—Epirubicin—uterine cancer	6.66e-05	0.000421	CcSEcCtD
Chenodeoxycholic acid—Vertigo—Doxorubicin—uterine cancer	6.65e-05	0.00042	CcSEcCtD
Chenodeoxycholic acid—Syncope—Doxorubicin—uterine cancer	6.63e-05	0.000419	CcSEcCtD
Chenodeoxycholic acid—Leukopenia—Doxorubicin—uterine cancer	6.62e-05	0.000418	CcSEcCtD
Chenodeoxycholic acid—Confusional state—Epirubicin—uterine cancer	6.58e-05	0.000416	CcSEcCtD
Chenodeoxycholic acid—Palpitations—Doxorubicin—uterine cancer	6.54e-05	0.000413	CcSEcCtD
Chenodeoxycholic acid—Oedema—Epirubicin—uterine cancer	6.53e-05	0.000412	CcSEcCtD
Chenodeoxycholic acid—Loss of consciousness—Doxorubicin—uterine cancer	6.5e-05	0.000411	CcSEcCtD
Chenodeoxycholic acid—Infection—Epirubicin—uterine cancer	6.48e-05	0.00041	CcSEcCtD
Chenodeoxycholic acid—Cough—Doxorubicin—uterine cancer	6.46e-05	0.000408	CcSEcCtD
Chenodeoxycholic acid—Shock—Epirubicin—uterine cancer	6.42e-05	0.000406	CcSEcCtD
Chenodeoxycholic acid—Convulsion—Doxorubicin—uterine cancer	6.41e-05	0.000405	CcSEcCtD
Chenodeoxycholic acid—Nervous system disorder—Epirubicin—uterine cancer	6.4e-05	0.000404	CcSEcCtD
Chenodeoxycholic acid—CYP27A1—Metabolism of lipids and lipoproteins—EP300—uterine cancer	6.39e-05	0.000677	CbGpPWpGaD
Chenodeoxycholic acid—Thrombocytopenia—Epirubicin—uterine cancer	6.39e-05	0.000404	CcSEcCtD
Chenodeoxycholic acid—Hypertension—Doxorubicin—uterine cancer	6.39e-05	0.000404	CcSEcCtD
Chenodeoxycholic acid—Tachycardia—Epirubicin—uterine cancer	6.37e-05	0.000402	CcSEcCtD
Chenodeoxycholic acid—Skin disorder—Epirubicin—uterine cancer	6.34e-05	0.0004	CcSEcCtD
Chenodeoxycholic acid—Hyperhidrosis—Epirubicin—uterine cancer	6.31e-05	0.000399	CcSEcCtD
Chenodeoxycholic acid—CYP3A4—Metapathway biotransformation—GPX3—uterine cancer	6.31e-05	0.000668	CbGpPWpGaD
Chenodeoxycholic acid—Myalgia—Doxorubicin—uterine cancer	6.3e-05	0.000398	CcSEcCtD
Chenodeoxycholic acid—Chest pain—Doxorubicin—uterine cancer	6.3e-05	0.000398	CcSEcCtD
Chenodeoxycholic acid—Arthralgia—Doxorubicin—uterine cancer	6.3e-05	0.000398	CcSEcCtD
Chenodeoxycholic acid—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	6.25e-05	0.000395	CcSEcCtD
Chenodeoxycholic acid—Discomfort—Doxorubicin—uterine cancer	6.22e-05	0.000393	CcSEcCtD
Chenodeoxycholic acid—Anorexia—Epirubicin—uterine cancer	6.22e-05	0.000393	CcSEcCtD
Chenodeoxycholic acid—Dry mouth—Doxorubicin—uterine cancer	6.16e-05	0.000389	CcSEcCtD
Chenodeoxycholic acid—Hypotension—Epirubicin—uterine cancer	6.1e-05	0.000385	CcSEcCtD
Chenodeoxycholic acid—Confusional state—Doxorubicin—uterine cancer	6.09e-05	0.000385	CcSEcCtD
Chenodeoxycholic acid—Oedema—Doxorubicin—uterine cancer	6.04e-05	0.000381	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Gene Expression—CDKN2B—uterine cancer	6.02e-05	0.000637	CbGpPWpGaD
Chenodeoxycholic acid—Infection—Doxorubicin—uterine cancer	6e-05	0.000379	CcSEcCtD
Chenodeoxycholic acid—Musculoskeletal discomfort—Epirubicin—uterine cancer	5.94e-05	0.000376	CcSEcCtD
Chenodeoxycholic acid—Shock—Doxorubicin—uterine cancer	5.94e-05	0.000375	CcSEcCtD
Chenodeoxycholic acid—CYP3A4—Biological oxidations—CYP11A1—uterine cancer	5.94e-05	0.000629	CbGpPWpGaD
Chenodeoxycholic acid—Nervous system disorder—Doxorubicin—uterine cancer	5.92e-05	0.000374	CcSEcCtD
Chenodeoxycholic acid—Thrombocytopenia—Doxorubicin—uterine cancer	5.91e-05	0.000374	CcSEcCtD
Chenodeoxycholic acid—Insomnia—Epirubicin—uterine cancer	5.9e-05	0.000373	CcSEcCtD
Chenodeoxycholic acid—Tachycardia—Doxorubicin—uterine cancer	5.89e-05	0.000372	CcSEcCtD
Chenodeoxycholic acid—Skin disorder—Doxorubicin—uterine cancer	5.86e-05	0.000371	CcSEcCtD
Chenodeoxycholic acid—Paraesthesia—Epirubicin—uterine cancer	5.86e-05	0.00037	CcSEcCtD
Chenodeoxycholic acid—CYP3A4—Metapathway biotransformation—CYP11A1—uterine cancer	5.86e-05	0.00062	CbGpPWpGaD
Chenodeoxycholic acid—Hyperhidrosis—Doxorubicin—uterine cancer	5.84e-05	0.000369	CcSEcCtD
Chenodeoxycholic acid—Dyspnoea—Epirubicin—uterine cancer	5.82e-05	0.000368	CcSEcCtD
Chenodeoxycholic acid—Somnolence—Epirubicin—uterine cancer	5.8e-05	0.000367	CcSEcCtD
Chenodeoxycholic acid—UGT2B7—Metabolism—POLD1—uterine cancer	5.8e-05	0.000614	CbGpPWpGaD
Chenodeoxycholic acid—Anorexia—Doxorubicin—uterine cancer	5.76e-05	0.000364	CcSEcCtD
Chenodeoxycholic acid—Dyspepsia—Epirubicin—uterine cancer	5.74e-05	0.000363	CcSEcCtD
Chenodeoxycholic acid—Decreased appetite—Epirubicin—uterine cancer	5.67e-05	0.000358	CcSEcCtD
Chenodeoxycholic acid—Hypotension—Doxorubicin—uterine cancer	5.64e-05	0.000356	CcSEcCtD
Chenodeoxycholic acid—Gastrointestinal disorder—Epirubicin—uterine cancer	5.63e-05	0.000356	CcSEcCtD
Chenodeoxycholic acid—Fatigue—Epirubicin—uterine cancer	5.63e-05	0.000355	CcSEcCtD
Chenodeoxycholic acid—Constipation—Epirubicin—uterine cancer	5.58e-05	0.000353	CcSEcCtD
Chenodeoxycholic acid—Pain—Epirubicin—uterine cancer	5.58e-05	0.000353	CcSEcCtD
Chenodeoxycholic acid—CYP3A4—Metapathway biotransformation—AKR1C3—uterine cancer	5.53e-05	0.000586	CbGpPWpGaD
Chenodeoxycholic acid—Musculoskeletal discomfort—Doxorubicin—uterine cancer	5.5e-05	0.000348	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Gene Expression—SMAD3—uterine cancer	5.49e-05	0.000582	CbGpPWpGaD
Chenodeoxycholic acid—Insomnia—Doxorubicin—uterine cancer	5.46e-05	0.000345	CcSEcCtD
Chenodeoxycholic acid—UGT2B7—Metabolism—AKR1C1—uterine cancer	5.42e-05	0.000575	CbGpPWpGaD
Chenodeoxycholic acid—Paraesthesia—Doxorubicin—uterine cancer	5.42e-05	0.000343	CcSEcCtD
Chenodeoxycholic acid—Dyspnoea—Doxorubicin—uterine cancer	5.38e-05	0.00034	CcSEcCtD
Chenodeoxycholic acid—Feeling abnormal—Epirubicin—uterine cancer	5.38e-05	0.00034	CcSEcCtD
Chenodeoxycholic acid—Somnolence—Doxorubicin—uterine cancer	5.37e-05	0.000339	CcSEcCtD
Chenodeoxycholic acid—CYP27A1—Metabolism—MTHFR—uterine cancer	5.37e-05	0.000569	CbGpPWpGaD
Chenodeoxycholic acid—Gastrointestinal pain—Epirubicin—uterine cancer	5.34e-05	0.000337	CcSEcCtD
Chenodeoxycholic acid—Dyspepsia—Doxorubicin—uterine cancer	5.31e-05	0.000336	CcSEcCtD
Chenodeoxycholic acid—Decreased appetite—Doxorubicin—uterine cancer	5.25e-05	0.000332	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Metabolism—CYP19A1—uterine cancer	5.22e-05	0.000553	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—STK11—uterine cancer	5.22e-05	0.000553	CbGpPWpGaD
Chenodeoxycholic acid—Gastrointestinal disorder—Doxorubicin—uterine cancer	5.21e-05	0.000329	CcSEcCtD
Chenodeoxycholic acid—Fatigue—Doxorubicin—uterine cancer	5.21e-05	0.000329	CcSEcCtD
Chenodeoxycholic acid—Urticaria—Epirubicin—uterine cancer	5.18e-05	0.000328	CcSEcCtD
Chenodeoxycholic acid—Constipation—Doxorubicin—uterine cancer	5.16e-05	0.000326	CcSEcCtD
Chenodeoxycholic acid—Pain—Doxorubicin—uterine cancer	5.16e-05	0.000326	CcSEcCtD
Chenodeoxycholic acid—Abdominal pain—Epirubicin—uterine cancer	5.16e-05	0.000326	CcSEcCtD
Chenodeoxycholic acid—Body temperature increased—Epirubicin—uterine cancer	5.16e-05	0.000326	CcSEcCtD
Chenodeoxycholic acid—Feeling abnormal—Doxorubicin—uterine cancer	4.98e-05	0.000314	CcSEcCtD
Chenodeoxycholic acid—Gastrointestinal pain—Doxorubicin—uterine cancer	4.94e-05	0.000312	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	4.9e-05	0.000519	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—RRM2—uterine cancer	4.83e-05	0.000512	CbGpPWpGaD
Chenodeoxycholic acid—Hypersensitivity—Epirubicin—uterine cancer	4.81e-05	0.000304	CcSEcCtD
Chenodeoxycholic acid—Urticaria—Doxorubicin—uterine cancer	4.8e-05	0.000303	CcSEcCtD
Chenodeoxycholic acid—Abdominal pain—Doxorubicin—uterine cancer	4.77e-05	0.000302	CcSEcCtD
Chenodeoxycholic acid—Body temperature increased—Doxorubicin—uterine cancer	4.77e-05	0.000302	CcSEcCtD
Chenodeoxycholic acid—CYP27A1—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	4.73e-05	0.000501	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—DCN—uterine cancer	4.69e-05	0.000497	CbGpPWpGaD
Chenodeoxycholic acid—Asthenia—Epirubicin—uterine cancer	4.68e-05	0.000296	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Metabolism of lipids and lipoproteins—EP300—uterine cancer	4.67e-05	0.000495	CbGpPWpGaD
Chenodeoxycholic acid—Pruritus—Epirubicin—uterine cancer	4.62e-05	0.000292	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Gene Expression—ESR1—uterine cancer	4.48e-05	0.000475	CbGpPWpGaD
Chenodeoxycholic acid—Diarrhoea—Epirubicin—uterine cancer	4.46e-05	0.000282	CcSEcCtD
Chenodeoxycholic acid—Hypersensitivity—Doxorubicin—uterine cancer	4.45e-05	0.000281	CcSEcCtD
Chenodeoxycholic acid—UGT2B7—Metabolism—CYP11A1—uterine cancer	4.42e-05	0.000468	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Biological oxidations—CYP19A1—uterine cancer	4.37e-05	0.000463	CbGpPWpGaD
Chenodeoxycholic acid—Asthenia—Doxorubicin—uterine cancer	4.33e-05	0.000274	CcSEcCtD
Chenodeoxycholic acid—Dizziness—Epirubicin—uterine cancer	4.31e-05	0.000273	CcSEcCtD
Chenodeoxycholic acid—CYP3A4—Metapathway biotransformation—CYP19A1—uterine cancer	4.31e-05	0.000456	CbGpPWpGaD
Chenodeoxycholic acid—Pruritus—Doxorubicin—uterine cancer	4.27e-05	0.00027	CcSEcCtD
Chenodeoxycholic acid—UGT2B7—Metabolism—AKR1C3—uterine cancer	4.17e-05	0.000442	CbGpPWpGaD
Chenodeoxycholic acid—Vomiting—Epirubicin—uterine cancer	4.15e-05	0.000262	CcSEcCtD
Chenodeoxycholic acid—Diarrhoea—Doxorubicin—uterine cancer	4.13e-05	0.000261	CcSEcCtD
Chenodeoxycholic acid—Rash—Epirubicin—uterine cancer	4.11e-05	0.00026	CcSEcCtD
Chenodeoxycholic acid—Dermatitis—Epirubicin—uterine cancer	4.11e-05	0.00026	CcSEcCtD
Chenodeoxycholic acid—Headache—Epirubicin—uterine cancer	4.09e-05	0.000258	CcSEcCtD
Chenodeoxycholic acid—Dizziness—Doxorubicin—uterine cancer	3.99e-05	0.000252	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Metabolism—MTHFR—uterine cancer	3.92e-05	0.000415	CbGpPWpGaD
Chenodeoxycholic acid—Nausea—Epirubicin—uterine cancer	3.88e-05	0.000245	CcSEcCtD
Chenodeoxycholic acid—Vomiting—Doxorubicin—uterine cancer	3.84e-05	0.000243	CcSEcCtD
Chenodeoxycholic acid—Rash—Doxorubicin—uterine cancer	3.81e-05	0.000241	CcSEcCtD
Chenodeoxycholic acid—Dermatitis—Doxorubicin—uterine cancer	3.8e-05	0.00024	CcSEcCtD
Chenodeoxycholic acid—Headache—Doxorubicin—uterine cancer	3.78e-05	0.000239	CcSEcCtD
Chenodeoxycholic acid—Nausea—Doxorubicin—uterine cancer	3.59e-05	0.000227	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	3.46e-05	0.000366	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—CYP19A1—uterine cancer	3.25e-05	0.000345	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—STK11—uterine cancer	3.25e-05	0.000345	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—PTEN—uterine cancer	2.99e-05	0.000316	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—EP300—uterine cancer	2.85e-05	0.000302	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—MTHFR—uterine cancer	2.44e-05	0.000259	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—SRD5A2—uterine cancer	2.35e-05	0.000249	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—NDUFB11—uterine cancer	2.35e-05	0.000249	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—PTEN—uterine cancer	2.18e-05	0.000231	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—PIK3CA—uterine cancer	2.11e-05	0.000223	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—EP300—uterine cancer	2.08e-05	0.00022	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—AKT1—uterine cancer	1.72e-05	0.000182	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—AKR1B1—uterine cancer	1.7e-05	0.00018	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—STAR—uterine cancer	1.7e-05	0.00018	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Gene Expression—AKT1—uterine cancer	1.62e-05	0.000171	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—PIK3CA—uterine cancer	1.54e-05	0.000163	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—PTEN—uterine cancer	1.36e-05	0.000144	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—POLD1—uterine cancer	1.33e-05	0.000141	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—EP300—uterine cancer	1.3e-05	0.000137	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—AKT1—uterine cancer	1.26e-05	0.000133	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—AKR1C1—uterine cancer	1.25e-05	0.000132	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—RRM2—uterine cancer	1.11e-05	0.000118	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—DCN—uterine cancer	1.08e-05	0.000114	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—CYP11A1—uterine cancer	1.02e-05	0.000108	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—PIK3CA—uterine cancer	9.59e-06	0.000102	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—AKR1C3—uterine cancer	9.59e-06	0.000102	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—AKT1—uterine cancer	7.84e-06	8.3e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—STK11—uterine cancer	7.47e-06	7.91e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—CYP19A1—uterine cancer	7.47e-06	7.91e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—MTHFR—uterine cancer	5.61e-06	5.95e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—PTEN—uterine cancer	3.12e-06	3.31e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—EP300—uterine cancer	2.98e-06	3.16e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—PIK3CA—uterine cancer	2.2e-06	2.33e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—AKT1—uterine cancer	1.8e-06	1.91e-05	CbGpPWpGaD
